Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?
Am J Gastroenterol
.
2020 Nov;115(11):1920-1921.
doi: 10.14309/ajg.0000000000000933.
Authors
Branden Tarlow
1
,
John Gubatan
1
,
Muhammad Ali Khan
2
,
George Cholankeril
3
Affiliations
1
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, California, USA.
2
Division of Gastroenterology and Hepatology, University of Alabama, Birmingham, Alabama, USA.
3
Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA.
PMID:
33156116
PMCID:
PMC7505035
DOI:
10.14309/ajg.0000000000000933
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus*
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
Proton Pump Inhibitors* / adverse effects
SARS-CoV-2
Substances
Proton Pump Inhibitors
Grants and funding
T32 DK007056/DK/NIDDK NIH HHS/United States